Mission: Parkinson's Therapeutics

Utilizing technology to tackle humanity's most debilitating diseases.

Technology

Vincere's platform of small molecules engage targets involved in Parkinson's disease. Target identification and rational compound design performed using exclusive license of patented simulation & AI from:




Funding

Validation of platform supported by private investment and:


 

More info: investor@VincereBio.com.

Pipeline

Multiple compounds engaging complementary targets in development.